Vergote I - Search Results

1

Colombo N, Van Gorp T, Parma G, Amant F, Gatta G, Sessa C, Vergote I. Colombo N, et al. Among authors: vergote i. Crit Rev Oncol Hematol. 2006 Nov;60(2):159-79. doi: 10.1016/j.critrevonc.2006.03.004. Epub 2006 Oct 2. Crit Rev Oncol Hematol. 2006. PMID: 17018256 Review.

2

Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.

Vergote I, De Smet I, Amant F. Vergote I, et al. Gynecol Oncol. 2002 Mar;84(3):537-8. doi: 10.1006/gyno.2001.6422. Gynecol Oncol. 2002. PMID: 11855893 No abstract available.

3

Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer.

Vergote I, Amant F, Berteloot P, Van Gramberen M. Vergote I, et al. Int J Gynecol Cancer. 2002 Jan-Feb;12(1):22-6. doi: 10.1046/j.1525-1438.2002.01070.x. Int J Gynecol Cancer. 2002. PMID: 11860532

4

PTEN mutation analysis in uterine leiomyosarcomas and mixed mullerian sarcomas.

Amant F, Vergote I. Amant F, et al. Among authors: vergote i. Am J Obstet Gynecol. 2002 Jul;187(1):258. doi: 10.1067/mob.2002.124942. Am J Obstet Gynecol. 2002. PMID: 12114928 No abstract available.

5

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.

Trimbos JB, Parmar M, Vergote I, Guthrie D, Bolis G, Colombo N, Vermorken JB, Torri V, Mangioni C, Pecorelli S, Lissoni A, Swart AM; International Collaborative Ovarian Neoplasm 1; European Organisation for Research and Treatment of Cancer Collaborators-Adjuvant ChemoTherapy un Ovarian Neoplasm. Trimbos JB, et al. Among authors: vergote i. J Natl Cancer Inst. 2003 Jan 15;95(2):105-12. J Natl Cancer Inst. 2003. PMID: 12529343 Clinical Trial.

6

Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study.

Keldsen N, Havsteen H, Vergote I, Bertelsen K, Jakobsen A. Keldsen N, et al. Among authors: vergote i. Gynecol Oncol. 2003 Feb;88(2):118-22. doi: 10.1016/s0090-8258(02)00103-8. Gynecol Oncol. 2003. PMID: 12586589 Clinical Trial.

7

Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels.

Amant F, Huys E, Geurts-Moespot A, Lindeque BG, Vergote I, Sweep F, Schoenmakers EF. Amant F, et al. Among authors: vergote i. J Soc Gynecol Investig. 2003 Feb;10(2):105-9. doi: 10.1016/s1071-5576(02)00253-8. J Soc Gynecol Investig. 2003. PMID: 12594000

8

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer.

D'Agostino G, Amant F, Berteloot P, Scambia G, Vergote I. D'Agostino G, et al. Among authors: vergote i. Gynecol Oncol. 2003 Mar;88(3):266-9. doi: 10.1016/s0090-8258(03)00011-8. Gynecol Oncol. 2003. PMID: 12648573 Clinical Trial.

9

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature.

Amant F, Moerman P, Cadron I, Hagemeijer A, Vergote I, Debiec-Rychter M. Amant F, et al. Among authors: vergote i. Gynecol Oncol. 2003 Mar;88(3):459-62. doi: 10.1016/s0090-8258(02)00096-3. Gynecol Oncol. 2003. PMID: 12648605 Review.

10

Immunohistochemical determination of hormone receptors in uterine adenosarcomas.

Amant F, Gabriel C, Moerman P, Vergote I. Amant F, et al. Among authors: vergote i. Gynecol Oncol. 2003 Mar;88(3):463-4. doi: 10.1016/s0090-8258(02)00006-9. Gynecol Oncol. 2003. PMID: 12648606 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

883 results

Search Page

Filters